Etravirine Induced Severe Hypersensitivity Reaction and Fulminant Hepatitis: A Case Report and Review of the Literature
- *Corresponding Author:
- Linda Nabha
Division of Infectious Diseases
Georgetown University Hospital, Washington DC 20007
3800 Reservoir Road, NW, 5-PHC, USA
E-mail: [email protected]
Received Date: October 20, 2011; Accepted Date: January 06, 2012; Published Date: January 10, 2012
Citation: Nabha L, Balba GP, Tuazon C, Kumar PN (2012) Etravirine Induced Severe Hypersensitivity Reaction and Fulminant Hepatitis: A Case Report and Review of the Literature. J AIDS Clinic Res S2:005. doi:10.4172/2155-6113.S2-005
Copyright: © 2012 Nabha L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
We report the first published case of etravirine induced hypersensitivity reaction leading to fulminant hepatic failure in a 49-year-old female patient with Human Immunodefi ciency Virus. She presented with a life threatening rash and end stage organ damage requiring intensive care unit supportive care. Liver biopsy supported the diagnosis of drug-induced hypersensitivity. The patient recovered after withdrawal of etravirine and the use of systemic corticosteroids. The authors describe etravirine drug hypersensitivity as a clinically important reaction and that early recognition can improve survival.